Bahing, Jerwen L.
HRN: 15-44-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2022
CEFTRIAXONE 1G (VIAL)
07/21/2022
07/28/2022
IVT
1 G
24 Hrs
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes